United Kingdom

People: Eagle Pharmaceuticals Inc (EGRX.OQ)

EGRX.OQ on NASDAQ Stock Exchange Global Market

9:00pm BST
Change (% chg)

$0.86 (+1.48%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Glenning, Robert 

Mr. Robert L. Glenning is Independent Director of Eagle Pharmaceuticals, Inc. since July 2016. Mr. Glenning has over 30 years of experience in the healthcare industry and since July 2016 has served as the president of the financial services and information service divisions and chief financial officer at Hackensack Meridian Health, a not-for-profit healthcare organization that is the most comprehensive health delivery network in the state of New Jersey, with anticipated revenues of over $4 billion annually. From 2007 to June 2016, he served as executive vice president and chief financial officer of Hackensack University Health Network. From 2002 to 2007, Mr. Glenning served as an executive vice president and chief financial officer of Kaleida Health Inc., the largest healthcare system in western New York. Prior to Kaleida Health, he served as vice president and chief financial officer of acute care at Northeast Health and Albany Memorial Hospital. Mr. Glenning began his career at PricewaterhouseCoopers. He earned his BBA from Siena College and his MBA from Clarkson University. He is a Certified Public Accountant (license currently inactive). Our Board believes that Mr. Glenning's extensive executive experience and background in the healthcare industry as well as his strong financial background qualifies him to serve on our Board.

Basic Compensation

Total Annual Compensation, USD 73,750
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 254,778
Fiscal Year Total, USD 328,528

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Michael Graves


David Pernock


Scott Tarriff


Pete Meyers


Adrian Hepner


Douglas Braunstein

As Of  31 Dec 2018